Interaction of mephedrone with dopamine and serotonin targets in rats - PubMed (original) (raw)

Interaction of mephedrone with dopamine and serotonin targets in rats

José Martínez-Clemente et al. Eur Neuropsychopharmacol. 2012 Mar.

Abstract

Introduction: We described a first approach to the pharmacological targets of mephedrone (4-methyl-methcathinone) in rats to establish the basis of the mechanism of action of this drug of abuse.

Experimental procedures: We performed in vitro experiments in isolated synaptosomes or tissue membrane preparations from rat cortex or striatum, studying the effect of mephedrone on monoamine uptake and the displacement of several specific radioligands by this drug.

Results: In isolated synaptosomes from rat cortex or striatum, mephedrone inhibited the uptake of serotonin (5-HT) with an IC ₅₀ value lower than that of dopamine (DA) uptake (IC ₅₀=0.31±0.08 and 0.97±0.0 5μM, respectively). Moreover, mephedrone displaced competitively both [³H]paroxetine and [³H]WIN35428 binding in a concentration-dependent manner (Ki values of 17.55±0.78μM and 1.53±0.47 μM, respectively), indicating a greater affinity for DA than for 5-HT membrane transporters. The affinity profile of mephedrone for the 5-HT₂ and D₂ receptors was assessed by studying [³H]ketanserin and [³H] raclopride binding in rat membranes. Mephedrone showed a greater affinity for the 5-HT₂ than for the D₂ receptors.

Discussion: These results provide evidence that mephedrone, interacting with 5-HT and DA transporters and receptors must display a similar pattern of other psychoactive drugs such as amphetamine-like compounds.

PubMed Disclaimer

Cited by

Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Angoa-Pérez M, Kane MJ, Briggs DI, Francescutti DM, Sykes CE, Shah MM, Thomas DM, Kuhn DM. Angoa-Pérez M, et al. J Neurochem. 2013 Apr;125(1):102-10. doi: 10.1111/jnc.12114. Epub 2013 Jan 8. J Neurochem. 2013. PMID: 23205838 Free PMC article.
Pharmacological characterization of designer cathinones in vitro.
Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME. Simmler LD, et al. Br J Pharmacol. 2013 Jan;168(2):458-70. doi: 10.1111/j.1476-5381.2012.02145.x. Br J Pharmacol. 2013. PMID: 22897747 Free PMC article.
Enantioseparation and Determination of Mephedrone and Its Metabolites by Capillary Electrophoresis Using Cyclodextrins as Chiral Selectors.
Řezanka P, Macková D, Jurok R, Himl M, Kuchař M. Řezanka P, et al. Molecules. 2020 Jun 23;25(12):2879. doi: 10.3390/molecules25122879. Molecules. 2020. PMID: 32585814 Free PMC article.
Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.
Glennon RA. Glennon RA. Adv Pharmacol. 2014;69:581-620. doi: 10.1016/B978-0-12-420118-7.00015-9. Adv Pharmacol. 2014. PMID: 24484988 Free PMC article. Review.
Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.
Oeri HE. Oeri HE. J Psychopharmacol. 2021 May;35(5):512-536. doi: 10.1177/0269881120920420. Epub 2020 Sep 10. J Psychopharmacol. 2021. PMID: 32909493 Free PMC article. Review.

Interaction of mephedrone with dopamine and serotonin targets in rats - PubMed (original) (raw)